| Typicality: | 0.363 |
| Saliency: | 0.265 |
| vaccine → be developed by → novartis | 7 |
| vaccine → be manufactured by → novartis | 6 |
| vaccine → be made by → novartis | 5 |
| vaccine → be produced by → novartis | 3 |
| negative | neutral | positive |
| 0.152 | 0.638 | 0.210 |
| Raw frequency | 21 |
| Normalized frequency | 0.265 |
| Modifier score | 0.500 |
| Perplexity | 58.029 |